Cancer Care Coordination for Chemotherapy Patients

NCT ID: NCT02238951

Last Updated: 2018-11-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-12-31

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare nurse-led care coordination for persons receiving cancer chemotherapy treatment incorporating mobile health technology to nurse-led care coordination without any mobile health enhancements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will randomize sixty (60) participants receiving cancer chemotherapy treatment to receive nurse-led care coordination using a HIPAA-compliant mobile health platform compared to no technology-enhanced care coordination.

All participants receive nurse-led care coordination throughout chemotherapy treatment.

RESEARCH AIMS:

* Demonstration of a HIPAA-compliant social networking platform;
* Facilitate communication and collaboration among patients with cancer and their care team;
* Assess patient health outcomes (chemotherapy-related physical and psychological side effects; pain, quality of life and patient satisfaction)
* Assessment of healthcare utilization including emergency department visits, unplanned clinic visits and hospitalization;
* For patients assigned to the mobile health care coordination, understanding their experience of use of the technology

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mobile Health (mHealth)

Care coordination using mHealth technology enhancements

Group Type EXPERIMENTAL

Mobile Health (mHealth)

Intervention Type OTHER

Participants receive care coordination throughout their chemotherapy treatment using mHealth technology

No mHealth

Care coordination without mHealth enhancements

Group Type ACTIVE_COMPARATOR

No mHealth

Intervention Type OTHER

Participants receive the same evidence-based care coordination without mHealth technology

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile Health (mHealth)

Participants receive care coordination throughout their chemotherapy treatment using mHealth technology

Intervention Type OTHER

No mHealth

Participants receive the same evidence-based care coordination without mHealth technology

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Android-based device Mobile health Patient Health Network

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Newly diagnosed cancer - any site or stage
* Initiating chemotherapy
* Ability to read and write English
* Manual dexterity sufficient to use a tablet technology
* Cognitive capacity to participate
* Preferential recruitment of publicly insured and/or living in rural communities

Exclusion Criteria

* Oral chemotherapy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

McKesson Foundation

OTHER

Sponsor Role collaborator

Boston University

OTHER

Sponsor Role collaborator

University of California, Davis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jill G Joseph, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of California, Davis Betty Irene Moore School of Nursing

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UC Davis Comprehensive Cancer Care Center

Sacramento, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

551190

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.